Journalartikel

Management of multiresistant pathogens in urology


AutorenlisteMagistro, G.; Gratzke, C.; Stief, C. G.; Weidner, W.; Wagenlehner, F.

Jahr der Veröffentlichung2015

Seiten267-274

ZeitschriftUrologe A

Bandnummer54

Heftnummer2

ISSN0340-2592

eISSN1433-0563

DOI Linkhttps://doi.org/10.1007/s00120-014-3640-z

VerlagSpringer


Abstract
Epidemiological data from recent years confirm the increasing problem of antimicrobial resistance not only for healthcare-associated, gram-positive pathogens but also for gram-negative bacteria. In particular, the progressive increase in resistance to third generation cephalosporins and carbapenems in Enterobacteriaceae is of great concern. With its contribution to infectious morbidity, mortality and financial costs to healthcare systems worldwide, multidrug-resistant pathogens emerge more and more as a public health issue of substantial socioeconomic importance. The Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute (RKI) decided to formulate novel definitions for multidrug-resistance in order to develop hygiene measures for infections and colonization with multidrug-resistant gram-negative bacilli.



Zitierstile

Harvard-ZitierstilMagistro, G., Gratzke, C., Stief, C., Weidner, W. and Wagenlehner, F. (2015) Management of multiresistant pathogens in urology, Urologe A, 54(2), pp. 267-274. https://doi.org/10.1007/s00120-014-3640-z

APA-ZitierstilMagistro, G., Gratzke, C., Stief, C., Weidner, W., & Wagenlehner, F. (2015). Management of multiresistant pathogens in urology. Urologe A. 54(2), 267-274. https://doi.org/10.1007/s00120-014-3640-z



Schlagwörter


3MRGN4MRGNMultidrug-resistant gram-negative bacilliRESISTANT


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-21-05 um 18:35